Filing Flows › Cerenome (CNSY) › R&D spending
Cerenome (CNSY) R&D spending by quarter
Cerenome's R&D spending was $4.3M in Q2 2026 (second quarter 2026), +49% from Q1 2026. Over the last 7 quarters it ranged from $1.2M (Q2 2025) to $4.3M (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $4.3M | +49% | +242% |
| Q1 2026 | $2.9M | -3% | +63% |
| Q4 2025 | $2.9M | +21% | +35% |
| Q3 2025 | $2.4M | +96% | — |
| Q2 2025 | $1.2M | -29% | — |
| Q1 2025 | $1.8M | -20% | — |
| Q4 2024 | $2.2M | — | — |
Q2 2026 at a glance
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Cerenome's R&D spending?
Cerenome's R&D spending was $4.3M in Q2 2026 (second quarter 2026), +49% from Q1 2026.
How has Cerenome's R&D spending changed?
Over the last 7 quarters it ranged from $1.2M (Q2 2025) to $4.3M (Q2 2026).